Table 1.

Patient clinical and demographic data.

	Severe COVID-19	Critical COVID-19	p Value
Age (years)	58.46 ± 15.80	65.65 ± 13.14	0.022
Male	21 (55.26%)	29 (76.31%)	0.154
Diabetes	3 (7.89%)	7 (18.42%)	0.398
Cardiovascular disease	2 (5.26%)	7 (18.42%)	0.206
Chronic obstructive pulmonary disease	1 (2.63%)	2 (5.26%)	0.840
Symptoms
Temperature (>37.3 °C)	18 (47.36%)	22 (57.89%)	0.655
paO2/FIO2	320.20 ± 60.09	119.13 ± 67.71	<0.0001
Days of illness before admission	6.27 ± 2.60	6.41 ± 3.37	0.819
Laboratory baseline
White blood cells	6887.00 ± 3749	13136 ± 1106	<0.0001
Neutrophils	69.44 ± 14.88	80.72 ± 15.67	<0.0001
Lymphocytes	25.80 ± 16.86	12.28 ± 12.89	<0.0001
Platelets	221216 ± 97386	236912 ± 125951	0.523
C-reactive protein	8.314 ± 6.993	13.76 ± 10.95	0.037
Troponin	29.14 ± 93.72	481.20 ± 1404	<0.0001
Urea	31.16 ± 18.40	59.00 ± 47.47	<0.0001
Creatinine	0.843 ± 0.196	1.414 ± 1.835	0.122
Aspartate aminotransferase	40.62 ± 33.03	34.76 ± 22.94	0.424
Alanine transaminase	34.76 ± 22.94	62.17 ± 74.60	0.028
Gamma-Glutamyltransferase	44.05 ± 34.49	84.60 ± 97.36	0.082
Lactate Dehydrogenase	293.5 ± 116.1	517.0 ± 447.5	0.0001
Albumin	3.891 ± 0.403	3.214 ± 0.480	<0.0001
Days of hospital stay	10.14 ± 6.204	19.14 ± 11.48	<0.0001
Survival	35 (92.10%)	18 (47.36%)	<0.0001